ArticleTherapeutic advances in hematology2021

Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia.

Nerea Báez-Gutiérrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.